Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$61.59+1.26 (+2.09%)
Close on Nov 13, 2026Market cap $9.55BP/E –Yield –
Bruker total assets
Total assets on the balance sheet at the end of each period.
Bruker's total assets was $5.83B at Sep 30, 2026. For fiscal 2025 it was $6.24B, up 7.5% from the year before. Over ten years it grew 13.7% a year on average. The highest annual figure on record is $6.24B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.24B | +7.5% |
| FY2024 | Dec 31, 2024 | $5.81B | +36.6% |
| FY2023 | Dec 31, 2023 | $4.25B | +17.7% |
| FY2022 | Dec 31, 2022 | $3.61B | -1.0% |
| FY2021 | Dec 31, 2021 | $3.65B | +19.7% |
| FY2020 | Dec 31, 2020 | $3.05B | +10.0% |
| FY2019 | Dec 31, 2019 | $2.77B | +30.2% |
| FY2018 | Dec 31, 2018 | $2.13B | +9.2% |
| FY2017 | Dec 31, 2017 | $1.95B | +7.7% |
| FY2016 | Dec 31, 2016 | $1.81B | +4.5% |
| FY2015 | Dec 31, 2015 | $1.73B | -7.2% |
| FY2014 | Dec 31, 2014 | $1.86B | -6.2% |
| FY2013 | Dec 31, 2013 | $1.99B | +7.1% |
| FY2012 | Dec 31, 2012 | $1.86B | +8.5% |
| FY2011 | Dec 31, 2011 | $1.71B | +10.4% |
| FY2010 | Dec 31, 2010 | $1.55B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.83B | -9.4% |
| Q2 FY2026 | Jun 30, 2026 | $6.05B | -4.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.13B | +3.3% |
| Q4 FY2025 | Dec 31, 2025 | $6.24B | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | $6.43B | +5.3% |
| Q2 FY2025 | Jun 30, 2025 | $6.34B | +7.4% |
| Q1 FY2025 | Mar 31, 2025 | $5.93B | +31.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.81B | +36.6% |
| Q3 FY2024 | Sep 30, 2024 | $6.11B | +60.0% |
| Q2 FY2024 | Jun 30, 2024 | $5.90B | +53.0% |
| Q1 FY2024 | Mar 31, 2024 | $4.51B | +19.7% |
| Q4 FY2023 | Dec 31, 2023 | $4.25B | +17.7% |
| Q3 FY2023 | Sep 30, 2023 | $3.82B | +14.5% |
| Q2 FY2023 | Jun 30, 2023 | $3.86B | +14.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.76B | +6.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.61B | -1.0% |
| Q3 FY2022 | Sep 30, 2022 | $3.34B | +6.7% |
| Q2 FY2022 | Jun 30, 2022 | $3.38B | +9.6% |
| Q1 FY2022 | Mar 31, 2022 | $3.55B | +17.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.65B | +19.7% |
| Q3 FY2021 | Sep 30, 2021 | $3.13B | +8.6% |
| Q2 FY2021 | Jun 30, 2021 | $3.09B | +4.9% |
| Q1 FY2021 | Mar 31, 2021 | $3.03B | +2.5% |
| Q4 FY2020 | Dec 31, 2020 | $3.05B | +10.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.88B | +22.4% |
| Q2 FY2020 | Jun 30, 2020 | $2.94B | +25.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.96B | +32.1% |
| Q4 FY2019 | Dec 31, 2019 | $2.77B | +30.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.35B | +24.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.35B | +30.1% |
| Q1 FY2019 | Mar 31, 2019 | $2.24B | +22.5% |
| Q4 FY2018 | Dec 31, 2018 | $2.13B | +9.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.89B | -3.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.81B | -5.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.83B | -0.5% |
| Q4 FY2017 | Dec 31, 2017 | $1.95B | +7.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.96B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.91B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.84B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.81B | – |
See a number that looks wrong?